Click here to view the July 2021 edition of eNews
Cambridge, UK: 30 June 2021
One Nucleus, the non-for-profit Life Science membership group headquartered in Cambridge exists to support growing Life Science businesses on their journey, including facilitating their business networking. BiotechBikers is a fast growing, informal global networking group in the Life Sciences space bringing together those with a social interest in cycling and biotech.
Dr Mark Farmery, founder of BiotechBikers commented, “Authentic and robust personal relationships are pivotal in successful collaboration and deal making. By engaging people around a shared passion…
AMSBIO have supplied custom lentivectors to Francesco Pampaloni and his team at the Buchmann Institute for Molecular Life Sciences (BMLS) in Frankfurt, Germany allowing them to visualize cell nuclei and F-actin cytoskeleton in their organoids.Organoids are morphologically heterogeneous 3-dimensional cell culture systems that provide an ideal model for understanding the principles of collective cell behavior in mammalian organs during development, homeostasis, regeneration, and pathogenesis. To investigate the underlying cell organization principles of organoids, BMLS researchers imaged…
Oxford, UK, 29 June 2021: PharmaVentures is pleased to announce that it acted as an independent technical and commercial expert with respect to Spectral MD’s listing on London’s AIM on June 22nd.Adrian Dawkes, Managing Director at PharmaVentures, said: “Through our expert knowledge across the medical device sector, and in particular the wound care market, we were pleased to be able to provide an independent expert assessment of Spectral’s DeepView® Wound Imaging System with respect to their Initial Public Offering (IPO) on AIM.”Fintan Walton, Chief Executive of PharmaVentures, said: “…
SOMERSET, N.J., June 28, 2021 – Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has been recognized by the Royal Society for the Prevention of Accidents (RoSPA) for demonstrating high health and safety standards.
Catalent received the gold Health and Safety Award for working hard to provide a safe, healthy and inclusive working environment for its staff, customers and contractors. This is the third consecutive year that Catalent…
NOTTINGHAM, UK – 29 June, 2021 – Life Science Newswire – Sygnature Discovery, the leading provider of integrated drug discovery services, has received a significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co. Financial details have not been disclosed.Sygnature is a world-class provider of outsourced drug discovery services to leading pharma and biotech companies. The business operates from two state-of-the-art science facilities in the UK, at BioCity in Nottingham and Alderley Park in Cheshire, employing over 450…
Cambridge, UK,– 29 June 2021: IONTAS Limited (IONTAS), a leader in the discovery and optimization of fully human antibodies, today announces that F-star Therapeutics, Inc. (NASDAQ: FSTX), has dosed the first patients in a Phase 1 clinical trial, with FS222, a CD137/PD-L1 bispecific antibody.
IONTAS applied its proprietary technology to generate a component utilized within FS222, which was subsequently licenced to F-star. The initiation of this trial adds to the growing portfolio of antibodies generated by IONTAS that are entering clinical trials.
António Parada, CEO at IONTAS, commented: “We…
Cambridge and London, UK, 29 June 2021: CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single and multi-organ microphysiological systems (MPS), today announced that King’s College London, an internationally renowned research university, has adopted the PhysioMimix™ Multi-Organ MPS. Following a successful research collaboration, King’s College London selected the system to create a unique human-relevant liver-intestinal model for characterizing and manipulating host-microbial interactions, to support improved outcomes in cirrhosis. Launched in March 20211, CN Bio…